- Home
- NC vs AVIR Comparison
NC vs AVIR Comparison
Compare NC & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NC
- AVIR
- Stock Information
- Founded
- NC 1913
- AVIR 2012
- Country
- NC United States
- AVIR United States
- Employees
- NC N/A
- AVIR N/A
- Industry
- NC Coal Mining
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- NC Energy
- AVIR Health Care
- Exchange
- NC Nasdaq
- AVIR Nasdaq
- Market Cap
- NC 247.6M
- AVIR 273.0M
- IPO Year
- NC N/A
- AVIR 2020
- Fundamental
- Price
- NC $40.57
- AVIR $3.75
- Analyst Decision
- NC
- AVIR Hold
- Analyst Count
- NC 0
- AVIR 1
- Target Price
- NC N/A
- AVIR $6.00
- AVG Volume (30 Days)
- NC 10.8K
- AVIR 406.5K
- Earning Date
- NC 08-06-2025
- AVIR 08-06-2025
- Dividend Yield
- NC 2.25%
- AVIR N/A
- EPS Growth
- NC N/A
- AVIR N/A
- EPS
- NC 4.61
- AVIR N/A
- Revenue
- NC $249,990,000.00
- AVIR N/A
- Revenue This Year
- NC N/A
- AVIR N/A
- Revenue Next Year
- NC N/A
- AVIR N/A
- P/E Ratio
- NC $8.79
- AVIR N/A
- Revenue Growth
- NC 14.71
- AVIR N/A
- 52 Week Low
- NC $25.19
- AVIR $2.46
- 52 Week High
- NC $45.50
- AVIR $4.15
- Technical
- Relative Strength Index (RSI)
- NC 53.78
- AVIR 70.64
- Support Level
- NC $40.28
- AVIR $3.63
- Resistance Level
- NC $42.71
- AVIR $3.78
- Average True Range (ATR)
- NC 1.71
- AVIR 0.14
- MACD
- NC -0.17
- AVIR 0.02
- Stochastic Oscillator
- NC 43.61
- AVIR 80.65
About NC NACCO Industries Inc.
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).